About
Technology
Issues
FAQ
Links
Official Page
FINAL RESULTS OF CALGB 50803 (ALLIANCE): A PHASE 2 TRIAL OF LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.